Valziflocept (BAX1810, TAK-752) is a recombinant soluble human FcgammaRIIb receptor that targets Fc and FcgammaR. FcgammaRs bind and neutralize pathogenic IgG, thus forming a decoy or scavenger receptor that can reduce the severity of autoimmune diseases. Valziflocept can be used in studies of autoimmune diseases such as systemic lupus erythematosus (SLE).
CAS Nummer:
[1804910-11-9]
Target-Kategorie:
Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten